Trials / Completed
CompletedNCT02028286
A 21 Day Pharmacokinetics Study in Papulopustular Rosacea
A Phase 1, Open Label, Multiple Center Study to Evaluate the Pharmacokinetics of Once-Daily CLS001 Topical Gel Under Maximal Use Conditions Administered for 21 Days in Subjects With Papulopustular Rosacea
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to characterize the pharmacokinetics of once daily topical gel and confirm that steady state conditions are reached under maximal use conditions following 3 weeks of daily applications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CLS001 |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-03-01
- First posted
- 2014-01-07
- Last updated
- 2014-04-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02028286. Inclusion in this directory is not an endorsement.